Kawai K, Tamai H, Mori T, Morita T, Matsubayashi S, Katayama S, Kuma K, Kumagai L F
Department of Psychosomatic Medicine, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
J Clin Endocrinol Metab. 1993 Sep;77(3):716-9. doi: 10.1210/jcem.77.3.7690362.
To determine the histological characteristics of hyperthyroid Graves' disease with undetectable TSH receptor antibodies (TRAb), we examined the thyroid histological findings of patients with hyperthyroidism who were referred for subtotal thyroidectomy and who lacked circulatory TRAb. Four patients had undetectable TRAb (6.4 +/- 4.2%) before treatment (group A). Their pathological and clinical findings were compared with those of four patients who had hyperthyroid Graves' disease with detectable TRAb (83.8 +/- 8.3%) before treatment (group B). The groups were matched for sex, age, duration of antithyroidal drug therapy, anti-Tg antibody, and antimicrosomal antibody levels. All patients were in a euthyroid state just before operation. Papillate hyperplastic epithelia in group A were significantly less severe than in group B. Enlarged colloids were not observed in two of the four patients in group A but were observed in all four patients in group B. Moderate or marked lymphocytic infiltrations were observed in all patients in group A but were virtually absent in group B. Based on these results, it is probable that hyperthyroid Graves' disease with undetectable TRAb titers represents an early stage or subtype of usual hyperthyroid Graves' disease in which there is marked or moderate lymphocytic infiltration.
为了确定促甲状腺激素受体抗体(TRAb)检测不到的甲状腺功能亢进型格雷夫斯病的组织学特征,我们检查了因甲状腺次全切除术前来就诊且循环中缺乏TRAb的甲状腺功能亢进患者的甲状腺组织学检查结果。4例患者治疗前TRAb检测不到(6.4±4.2%)(A组)。将他们的病理和临床结果与4例治疗前TRAb可检测到(83.8±8.3%)的甲状腺功能亢进型格雷夫斯病患者(B组)进行比较。两组在性别、年龄、抗甲状腺药物治疗持续时间、抗Tg抗体和抗微粒体抗体水平方面相匹配。所有患者在手术前均处于甲状腺功能正常状态。A组的乳头状增生上皮比B组明显较轻。A组4例患者中有2例未观察到胶体增大,而B组4例患者均观察到。A组所有患者均观察到中度或明显的淋巴细胞浸润,而B组几乎没有。基于这些结果,TRAb滴度检测不到的甲状腺功能亢进型格雷夫斯病可能代表了通常的甲状腺功能亢进型格雷夫斯病的早期阶段或亚型,其中存在明显或中度的淋巴细胞浸润。